Anna Oliver-Vazquez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Association of α-synuclein seed-amplification kinetics with cognitive decline in idiopathic Parkinson's disease.

Association of α-synuclein seed-amplification kinetics with cognitive decline in idiopathic Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: May 17, 2026

Spontaneous speech and language measures as predictive biomarkers of clinically meaningful disease progression and neurodegeneration in Huntington's disease.

Spontaneous speech and language measures as predictive biomarkers of clinically meaningful disease progression and neurodegeneration in Huntington's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: February 02, 2026

Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood.

Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood.

Journal: Parkinsonism & related disorders

Published: November 30, 2025

Neural and biomarker correlates of the Parkinson's Disease-Cognitive Rating Scale in Huntington's disease.

Neural and biomarker correlates of the Parkinson's Disease-Cognitive Rating Scale in Huntington's disease.

Journal: Neuroimage. Reports

Published: October 28, 2025

The profiling of extracellular vesicle subtypes in Huntington's disease brains identifies Alix as a novel marker of neuropathology.

The profiling of extracellular vesicle subtypes in Huntington's disease brains identifies Alix as a novel marker of neuropathology.

Journal: Acta neuropathologica communications

Published: July 17, 2025

Consolidation deficits in episodic memory define distinct clinical and neurodegenerative profiles in Huntington's disease.

Consolidation deficits in episodic memory define distinct clinical and neurodegenerative profiles in Huntington's disease.

Journal: NeuroImage. Clinical

Published: May 08, 2025

CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline.

CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline.

Journal: Annals of clinical and translational neurology

Published: December 14, 2024

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes.

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 05, 2024

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models.

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models.

Journal: Translational neurodegeneration

Published: November 27, 2024

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers.

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers.

Journal: International journal of molecular sciences

Published: October 17, 2024

Skin Tau Quantification as a Novel Biomarker in Huntington's Disease.

Skin Tau Quantification as a Novel Biomarker in Huntington's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: May 02, 2024

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model.

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model.

Journal: Brain stimulation

Published: September 20, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026